Detalhe da pesquisa
1.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Blood
; 132(16): 1703-1713, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190321
2.
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
Ann Hematol
; 96(8): 1361-1372, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612220